Resistance to endocrine therapy in HR + and/or HER2 + breast cancer: the most promising predictive biomarkers
Flávia Sardela de Miranda, Hugo Prazeres, Fernando Mendes, Diana Martins, Fernando Schmitt
Topics & Concepts
Breast cancerMedicineCancerTargeted therapyMetastatic breast cancerOncologyPI3K/AKT/mTOR pathwayDiseaseInternal medicineEndocrine systemBioinformaticsCancer researchBiologySignal transductionHormoneBiochemistryAdvanced Breast Cancer TherapiesCancer Genomics and DiagnosticsPI3K/AKT/mTOR signaling in cancer